All categories: Actigraphy | Affect and Personality | ApoE and TOMM40 | Blood Measures | Brain Proteins | Clinical Diagnosis | Cognition | Decision Making and Behavioral Economics | Demographics | Depression | Digital Pen Device | Disabilities | Female Reproductive History | Frailty | Lifestyle | Medical Conditions | Medicare Claims | Medications | Metabolism | Metabolomics | Motor and Gait | Neck, Low Back and Joint Pain | Neuroimaging | Nutrition | Olfaction | Pathology | Pulmonary Function | Sleep and Circadian Rhythms | SES and Cognitive Resources | Vision | Well-being
Currently filtering using: All categories and variables
Measures of metabolism
This data set is available for a subset of ROS participants.
Basal and insulin-stimulated levels of signaling and regulating kinases upstream and downstream in the IR→IRS-1/2→PI3K→Akt pathway are quantified using ex vivo stimulation, Western blotting, and quantitative immunohistochemistry.
Insulin and IGF-1 responsiveness are tested in the hippocampal formation.
Reference: Talbot K, Wang HY, Kazi H, Han LY, Bakshi KP, Stucky A, Fuino RL, Kawaguchi KR, Samoyedny AJ, Wilson RS, Arvanitakis Z, Schneider JA, Wolf BA, Bennett DA, Trojanowski JQ, Arnold SE: Demonstrated brain insulin resistance in Alzheimer’s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. J Clin Invest 2012, 122(4):1316-38.